SYNLOGIC, INC. Cash and Cash Equivalents, Period Increase (Decrease)
SYNLOGIC, INC. (SYBX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$1.21 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-04.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2017-08-04
- 2017-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month -$1.21M.
- 2016-06-30: Cash and Cash Equivalents, Period Increase (Decrease) 6 month -$58.92M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 6 month |
|---|---|
| 2017-06-30 | -$1.21M 10-Q · filed 2017-08-04 |
| 2016-06-30 | -$58.92M 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |